StoryFunding
Structure completes $281.5M private placement; raises additional capital for clinical expansion
Structure Therapeutics raised $281.5 million in a private placement offering, accelerating clinical development of aleniglipron and other programs.
- Private placement raised $281.5 million.
- Capital supports advancement of aleniglipron Phase II program.
- Strong demand from investors reflects confidence in oral GLP-1 efficacy data.